The 20 references in paper V. Gaynitdinova V., L. Sharafutdinova A., I. Kamaltdinov M., S. Avdeev N., В. Гайнитдинова В., Л. Шарафутдинова А., И. Камалтдинов М., С. Авдеев Н. (2015) “Сила адгезии, жесткость мембраны нейтрофилов и биомаркеры системного воспаления у больных хронической обструктивной болезнью легких с легочной гипертензией // Adhesion force, neutrophil membrane stiffness and systemic inflammation biomarkers in patients with chronic obstructive pulmonary disease and pulmonary hypertension” / spz:neicon:pulmonology:y:2014:i:6:p:33-39

1
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. Last updated 2014. www.goldcopd.org
(check this in PDF content)
2
Tania N.P., Schmidt M., Gosens R. Activin-A: active in inflammation in COPD. Eur. Respir. J.2014; 43 (4): 954–955.
(check this in PDF content)
3
Wouters E.F. Local and Systemic Inflammation in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005; 2 (1): 26–33.
(check this in PDF content)
4
Blidberg K., Palmberg L., Jameet A. Adhesion molecule sin subjects with COPD and healthynon-smokers: a cross sectional parallel group study. Respir. Res.2013; 14: 47.
(check this in PDF content)
5
Noguera A., Batle S., Miralles C. et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax. 2001; 56 (6): 432–437.
(check this in PDF content)
6
Bailey K.L., Goraya J., Rennard S.L. The Role of Systemic Inflammation in COPD. In: Nici L., ZuWallack R., eds. Chronic Obstructive Pulmonary Disease: Co-Morbidities and Systemic Consequences. New York: Humana Press. 2012; 12: 15–30.
(check this in PDF content)
7
Авдеев С.Н. Современные подходы к диагностике и терапии легочной гипертензии у пациентов с хронической обструктивной болезнью легких. Пульмонология. 2009; 1: 90–101.
(check this in PDF content)
8
Sin D.D., Paul Man S.F. Is Systemic inflammation responsible for pulmonary hypertension in COPD? Chest. 2006; 130: 310–312.
(check this in PDF content)
9
Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A.G. Mortality in COPD: Role of comorbidities. Eur. Respir. J. 2006; 28: 1245–1257.
(check this in PDF content)
10
Peinado V.I., Barbera J.A., Abate P. et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease.Am. J. Respir. Crit. Care Med.1999; 159: 1605–1611.
(check this in PDF content)
11
Roca-Cusachs P., Almendros I., Sunyer R. et al. Rheology of passive and adhesion-activated neutrophils probed by atomic force microscopy. Biophysical. J.2006; 91: 3508–3518.
(check this in PDF content)
12
Подосинников И.В., Нилова Л.Г., Бабичев И.В. Метод определения хемотаксической активности лейкоцитов. Лабораторное дело. 1981; 8: 68–70.
(check this in PDF content)
13
Bukharaev A.A., Mozhanova A.A., Nurgazizov N.I., Ovchinnikov D.V. Measuring local elastic properties of cell surfaces and soft materials in liquid by atomic force microspory. Phys. Low-Dimension Structures. 2003; 3–4: 31–38.
(check this in PDF content)
14
Thomsen M., Dahl M., Lange P. et al. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am. J. Respir. Crit Care Med. 2012; 186 (10): 982–988.
(check this in PDF content)
15
Garcia-Rio F., Miravitlles M., Soriano J.B. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir. Res.2010; 11: 63.
(check this in PDF content)
16
Joppa P., Petrasova D., Stancak B., Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest. 2006; 130 (2): 326–333.
(check this in PDF content)
17
Fujita M., Shannon J.M., Irvin C.G. et al. Over expression of tumor necrosis factor-produced an increase in lung volumes and pulmonary hypertension. Am. J. Physiol. Lung Cell Mol. Physiol.2001; 280: 39–49.
(check this in PDF content)
18
Riise G.C., Larsson S., Lofdahl C.G., Andersson B.A. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis.Eur. Respir. J. 1994; 7: 1673–1677.
(check this in PDF content)
19
Sanchez-Madrid F., del Poro M.A. Leukocyte polarization in cell migration and immune interactions. EMBO J. 1999; 18: 501–511.
(check this in PDF content)
20
Keatings V.M., Jatakanon A., Worsdell Y.M. et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.Am. J. Resp. Crit. Care Med.1997; 155: 542–548. Поступила 22.04.14
(check this in PDF content)